Anthropic says Claude aided early drug work with six partners
Reported lab results include a CAR-T design about 70% shorter and about 35,000 antibody designs.
1
Stories per day · 30 days
2 RSS
Relatedopenai4drug-discovery3acquisition2claude2gpt-rosalind2academic-access1academic-plan1ai-agents1anthropic1antibodies1biopharma1drug-design1neurotoxins1orchestra-bio1product-launch1protein-design1rosalind1trusted-access1
9 stories, newest first · one card per story
Stories tagged #life-sciences
OpenAI acquires Orchestra Bio for drug-development AI agents
Orchestra will fold into Rosalind; terms were not disclosed, and OpenAI already works with Novo Nordisk and Moderna.
Claude designed lab-tested binders against scorpion neurotoxins
Of 211 designs tested by two CROs, 17 met binding criteria; cellular neutralization was not confirmed.
1
OpenAI acquires Orchestra Bio to extend Rosalind life-sciences tools
Orchestra’s drug-program agents will join GPT-Rosalind and Rosalind Workbench to coordinate studies and timelines.
OpenAI's new Rosalind Academic Plan gives research labs up to 30 free seats for a year
OpenAI's Rosalind Academic Plan gives eligible US research labs up to 30 free seats for a year.
Bringing GPT-Rosalind to academic research labs
OpenAI launched the Rosalind Academic Plan, giving eligible U.S. labs free GPT-Rosalind access for up to a year.
8
Claude discovers a novel enzyme system with CRISPR-like repeats
Anthropic says Claude found a novel phage enzyme system with CRISPR-like DNA repeats.
Anthropic is setting up a biology lab where Claude guides robots through drug experiments
Anthropic is building a San Francisco biology lab where Claude directs robots in physical drug experiments.
Anthropic is operating a lab that conducts biology experiments
Anthropic confirms it runs a wet biology lab where AI models conduct physical experiments, raising biosecurity and customer-competition concerns.
1